0
IRVINE, Calif., March 04, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (NYSE:AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced that Marc Forth, AEON’s President and Chief Executive Officer, will present a corporate overview at the Leerink Global Healthcare Conference being held March 10 – 12, 2025 in Miami, FL.
Leerink Global Healthcare Conference
| Format: | Corporate Presentation | |
